ATAD2 and cancer: The close association between ATAD2 and malignancies suggests that ATAD2 has multifaceted oncogenic effects and is not only an emerging biomarker for the diagnosis and prognosis of many malignant tumors but also a potential drug target for the therapy of malignancies.